Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Cyclosporine for GVHD Prophylaxis in Pediatric HSCT
NCT01788501Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2011
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus + Wuzhi capsule in graft-versus-host disease (GVHD), sponsored by Seoul National University Hospital. Started Nov 2011; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01788501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788501.